Terms ending in 2039
Every in-force patent on Unity Biotechnology, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,703,745 | Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer In force · High confidence | Unity Biotechnology, Inc. | In force | High confidence | |
| US 10,738,042 | Phosphonamidates that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer In force · High confidence | Unity Biotechnology, Inc. | In force | High confidence | |
| US 10,745,429 | Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer In force · High confidence | Unity Biotechnology, Inc. | In force | High confidence | |
| US 10,717,722 | Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer In force · Medium confidence | Unity Biotechnology, Inc. | In force | Medium confidence | |
| US 10,981,892 | Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer In force · Low confidence | Unity Biotechnology, Inc. | In force | Low confidence | |
| US 12,221,433 | Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer In force · Low confidence | Unity Biotechnology, Inc. | In force | Low confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.